Drugs / TMC589337
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00908414 | May → Oct 2009 | HIV infectious disease | Tibotec Pharmaceuticals, Ireland | Withdrawn | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TMC589337 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00908414 ↗ |
| Route | Oral | “increasing single oral doses of TMC589337 and TMC589354” NCT00908414 ↗ |